PT3468603T - Variantes do fec-gm e métodos de utilização - Google Patents
Variantes do fec-gm e métodos de utilizaçãoInfo
- Publication number
- PT3468603T PT3468603T PT178109203T PT17810920T PT3468603T PT 3468603 T PT3468603 T PT 3468603T PT 178109203 T PT178109203 T PT 178109203T PT 17810920 T PT17810920 T PT 17810920T PT 3468603 T PT3468603 T PT 3468603T
- Authority
- PT
- Portugal
- Prior art keywords
- methods
- csf variants
- csf
- variants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662347342P | 2016-06-08 | 2016-06-08 | |
US201662374068P | 2016-08-12 | 2016-08-12 | |
US201662423857P | 2016-11-18 | 2016-11-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3468603T true PT3468603T (pt) | 2022-07-21 |
Family
ID=60573606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT178109203T PT3468603T (pt) | 2016-06-08 | 2017-06-07 | Variantes do fec-gm e métodos de utilização |
Country Status (15)
Country | Link |
---|---|
US (2) | US10562948B2 (pt) |
EP (1) | EP3468603B1 (pt) |
JP (2) | JP7050007B2 (pt) |
KR (1) | KR20190017868A (pt) |
CN (1) | CN109328071B (pt) |
AU (1) | AU2017277438A1 (pt) |
CA (1) | CA3026803A1 (pt) |
DK (1) | DK3468603T3 (pt) |
ES (1) | ES2913497T3 (pt) |
IL (1) | IL263379A (pt) |
MA (1) | MA45257A (pt) |
PT (1) | PT3468603T (pt) |
TW (1) | TW201808987A (pt) |
UY (1) | UY37281A (pt) |
WO (1) | WO2017214249A2 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB202214445D0 (en) * | 2022-09-30 | 2022-11-16 | Imp College Innovations Ltd | Gene therapy |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988007089A1 (en) | 1987-03-18 | 1988-09-22 | Medical Research Council | Altered antibodies |
US20080076706A1 (en) * | 1997-07-14 | 2008-03-27 | Bolder Biotechnology, Inc. | Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof |
EP1881005B1 (en) * | 1997-07-14 | 2013-04-03 | Bolder Biotechnology, Inc. | Derivatives of G-CSF and related proteins |
US7153943B2 (en) * | 1997-07-14 | 2006-12-26 | Bolder Biotechnology, Inc. | Derivatives of growth hormone and related proteins, and methods of use thereof |
US6670127B2 (en) | 1997-09-16 | 2003-12-30 | Egea Biosciences, Inc. | Method for assembly of a polynucleotide encoding a target polypeptide |
ATE462004T1 (de) | 1997-09-16 | 2010-04-15 | Centocor Inc | Methoden zur kompletten chemischen synthese und zusammensetzung von genen und genomen |
US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
KR20030082962A (ko) | 2001-03-08 | 2003-10-23 | 메르크 파텐트 게엠베하 | 감소된 면역원성을 갖는 개질된과립구대식세포집락자극인자(gm-csf) |
CN1233823C (zh) * | 2001-04-13 | 2005-12-28 | 上海华康生物技术有限公司 | 抗原致敏的人gm-csf基因修饰的人树突状细胞、其制法和用途 |
AU2003263552A1 (en) * | 2002-09-09 | 2004-03-29 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
GB0317999D0 (en) * | 2003-07-31 | 2003-09-03 | Univ Liege | Improvements in or relating to drug delivery systems |
MX2007000568A (es) * | 2004-07-16 | 2007-03-30 | Nektar Therapeutics Al Corp | Conjugados de una fraccion gm-csf y un polimero. |
WO2007009208A1 (en) | 2005-06-02 | 2007-01-25 | Cangene Corporation | Poly(ethylene glocol) modified human gm-csf with increased biological activity |
CN100579988C (zh) * | 2007-04-02 | 2010-01-13 | 中国疾病预防控制中心病毒病预防控制所 | 白喉毒素与gm-csf突变体的融合蛋白及其编码基因与应用 |
PT2506871T (pt) | 2009-11-30 | 2016-11-07 | Janssen Biotech Inc | Mutantes de fc de anticorpos com funções efetoras inutilizadas |
SI2948559T1 (en) * | 2013-01-25 | 2018-08-31 | Janssen Biotech, Inc. | KV1.3 antagonists and application procedures |
-
2017
- 2017-06-06 TW TW106118632A patent/TW201808987A/zh unknown
- 2017-06-07 PT PT178109203T patent/PT3468603T/pt unknown
- 2017-06-07 WO PCT/US2017/036316 patent/WO2017214249A2/en unknown
- 2017-06-07 CN CN201780035659.2A patent/CN109328071B/zh active Active
- 2017-06-07 EP EP17810920.3A patent/EP3468603B1/en active Active
- 2017-06-07 KR KR1020197000107A patent/KR20190017868A/ko active IP Right Grant
- 2017-06-07 JP JP2018564203A patent/JP7050007B2/ja active Active
- 2017-06-07 US US15/616,216 patent/US10562948B2/en not_active Expired - Fee Related
- 2017-06-07 DK DK17810920.3T patent/DK3468603T3/da active
- 2017-06-07 CA CA3026803A patent/CA3026803A1/en active Pending
- 2017-06-07 AU AU2017277438A patent/AU2017277438A1/en not_active Abandoned
- 2017-06-07 MA MA045257A patent/MA45257A/fr unknown
- 2017-06-07 ES ES17810920T patent/ES2913497T3/es active Active
- 2017-06-08 UY UY0001037281A patent/UY37281A/es unknown
-
2018
- 2018-11-29 IL IL263379A patent/IL263379A/en unknown
-
2020
- 2020-01-17 US US16/746,052 patent/US11208450B2/en active Active
-
2021
- 2021-11-24 JP JP2021190614A patent/JP2022043051A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP3468603B1 (en) | 2022-04-13 |
UY37281A (es) | 2018-01-02 |
US10562948B2 (en) | 2020-02-18 |
EP3468603A4 (en) | 2020-01-22 |
CN109328071A (zh) | 2019-02-12 |
JP2022043051A (ja) | 2022-03-15 |
JP7050007B2 (ja) | 2022-04-07 |
EP3468603A2 (en) | 2019-04-17 |
TW201808987A (zh) | 2018-03-16 |
WO2017214249A3 (en) | 2018-01-18 |
US20170355742A1 (en) | 2017-12-14 |
US11208450B2 (en) | 2021-12-28 |
MA45257A (fr) | 2019-04-17 |
KR20190017868A (ko) | 2019-02-20 |
US20200148736A1 (en) | 2020-05-14 |
CA3026803A1 (en) | 2017-12-14 |
ES2913497T3 (es) | 2022-06-02 |
CN109328071B (zh) | 2021-07-20 |
JP2019524062A (ja) | 2019-09-05 |
AU2017277438A1 (en) | 2018-12-13 |
IL263379A (en) | 2018-12-31 |
DK3468603T3 (da) | 2022-05-30 |
WO2017214249A2 (en) | 2017-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL286316A (en) | New micro-dystrophins and related method of use | |
IL290571A (en) | Molecules that bind pd-1 and methods of using them | |
HK1259232A1 (zh) | Menin-mll的取代抑制劑及其使用方法 | |
HK1252827A1 (zh) | 結合lag-3的分子和其使用方法 | |
IL250415B (en) | Antibodies against pd-l and methods of using them | |
IL282572B (en) | Tetrahydropyranylamino-pyrrolopyrimidinone and methods of using it | |
IL267291A (en) | Actonucleotidase inhibitors and methods of using them | |
HK1253049A1 (zh) | 糖基相互作用化合物及其使用方法 | |
IL282482A (en) | Variants of protoxin-II and methods of use | |
IL282508A (en) | Variants of protoxin-II and methods of use | |
IL265881A (en) | Inhaler and methods of use thereof | |
IL263379A (en) | gm-csf variants and methods to use | |
GB201509977D0 (en) | Dispensers and methods of use thereof | |
SG10201912615PA (en) | Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof | |
GB201416797D0 (en) | Contianer and method of use thereof |